 | • レポートコード：MRC2-11QY10444 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は全身性エリテマトーデス（SLE）治療薬のグローバル市場について調査・分析したレポートです。種類別（コルチコステロイド、非ステロイド性抗炎症薬（NSAID）、抗炎症薬、疾患修飾性抗リウマチ薬（DMARD）、抗マラリア薬、BLyS特異的阻害薬・モノクローナル抗体（MAbS）、免疫抑制剤・免疫調節薬）市場規模、用途別（静脈内、亜皮膚、経口、局所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別全身性エリテマトーデス（SLE）治療薬の競争状況、市場シェア ・世界の全身性エリテマトーデス（SLE）治療薬市場：種類別市場規模 2015年-2020年（コルチコステロイド、非ステロイド性抗炎症薬（NSAID）、抗炎症薬、疾患修飾性抗リウマチ薬（DMARD）、抗マラリア薬、BLyS特異的阻害薬・モノクローナル抗体（MAbS）、免疫抑制剤・免疫調節薬） ・世界の全身性エリテマトーデス（SLE）治療薬市場：種類別市場規模予測 2021年-2026年（コルチコステロイド、非ステロイド性抗炎症薬（NSAID）、抗炎症薬、疾患修飾性抗リウマチ薬（DMARD）、抗マラリア薬、BLyS特異的阻害薬・モノクローナル抗体（MAbS）、免疫抑制剤・免疫調節薬） ・世界の全身性エリテマトーデス（SLE）治療薬市場：用途別市場規模 2015年-2020年（静脈内、亜皮膚、経口、局所） ・世界の全身性エリテマトーデス（SLE）治療薬市場：用途別市場規模予測 2021年-2026年（静脈内、亜皮膚、経口、局所） ・北米の全身性エリテマトーデス（SLE）治療薬市場分析：米国、カナダ ・ヨーロッパの全身性エリテマトーデス（SLE）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの全身性エリテマトーデス（SLE）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の全身性エリテマトーデス（SLE）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの全身性エリテマトーデス（SLE）治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Anthera Pharmaceuticals、GSK、ImmuPharma、Johnson & Johnson ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and destroy healthy tissues in the body rather than foreign infectious agents. These autoantibodies cause inflammation, pain, and damage. It is also known as a disease of flare-ups and remissions and can range from mild to life threatening in severity. No cure for SLE yet exists.
Global Systemic Lupus Erythematous (SLE) Drugs market is projected to grow due to high prevalence of autoimmune diseases particularly systemic lupus erythematous (SLE). Major drivers for global systemic erythematous drugs market are development of novel SLE therapies, increasing availability of bio similar drugs and increasing support for emerging research areas for new drug molecules. At the same time, increasing awareness of disease diagnosis and treatment as well as consistent research and development processes for novel drug molecules are important drivers for global lupus erythematous market. Additionally, safety and quality of systemic lupus erythematous controlling therapy may possibly be a challenge for the growth of the global systemic lupus erythematous drugs market. Moreover, numerous public awareness programs targeted to increase awareness levels are also being accompanied. For instance, Lupus Foundation of America (LFA) has been implementing various projects to increase central support for SLE research and services to support people and families affected by SLE. However, serious side effectswith steroids, sensitivity with antibiotics, limited usage of Benlysta for severe SLE patients, and stringent regulatory approvals for new treatment options with better levels of efficacy and safety are obstructing the global systemic lupus erythematous drugs market.
Market Analysis and Insights: Global Systemic Lupus Erythematosus (SLE) Drugs Market
The global Systemic Lupus Erythematosus (SLE) Drugs market size is projected to reach US$ 168.3 million by 2026, from US$ 156.4 million in 2020, at a CAGR of 6.8%% during 2021-2026.
Global Systemic Lupus Erythematosus (SLE) Drugs Scope and Market Size
Systemic Lupus Erythematosus (SLE) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Systemic Lupus Erythematosus (SLE) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Systemic Lupus Erythematosus (SLE) Drugs market is segmented into
Corticosteroids
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Anti-Inflammatories
Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
Antimalarials
BLyS-Specific Inhibitors or Monoclonal Antibodies (MAbS)
Immunosuppressive Agents/Immune Modulators
Anticoagulants
Segment by Application, the Systemic Lupus Erythematosus (SLE) Drugs market is segmented into
Intravenous
Sub-Cutaneous
Oral
Topical
Regional and Country-level Analysis
The Systemic Lupus Erythematosus (SLE) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Systemic Lupus Erythematosus (SLE) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Systemic Lupus Erythematosus (SLE) Drugs Market Share Analysis
Systemic Lupus Erythematosus (SLE) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Systemic Lupus Erythematosus (SLE) Drugs business, the date to enter into the Systemic Lupus Erythematosus (SLE) Drugs market, Systemic Lupus Erythematosus (SLE) Drugs product introduction, recent developments, etc.
The major vendors covered:
Anthera Pharmaceuticals
GSK
ImmuPharma
Johnson & Johnson
…
1 Study Coverage
1.1 Systemic Lupus Erythematosus (SLE) Drugs Product Introduction
1.2 Market Segments
1.3 Key Systemic Lupus Erythematosus (SLE) Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Systemic Lupus Erythematosus (SLE) Drugs Market Size Growth Rate by Type
1.4.2 Corticosteroids
1.4.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.4.4 Anti-Inflammatories
1.4.5 Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
1.4.6 Antimalarials
1.4.7 BLyS-Specific Inhibitors or Monoclonal Antibodies (MAbS)
1.4.8 Immunosuppressive Agents/Immune Modulators
1.4.9 Anticoagulants
1.5 Market by Application
1.5.1 Global Systemic Lupus Erythematosus (SLE) Drugs Market Size Growth Rate by Application
1.5.2 Intravenous
1.5.3 Sub-Cutaneous
1.5.4 Oral
1.5.5 Topical
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Systemic Lupus Erythematosus (SLE) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Systemic Lupus Erythematosus (SLE) Drugs Revenue 2015-2026
2.1.2 Global Systemic Lupus Erythematosus (SLE) Drugs Sales 2015-2026
2.2 Global Systemic Lupus Erythematosus (SLE) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Systemic Lupus Erythematosus (SLE) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Systemic Lupus Erythematosus (SLE) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Systemic Lupus Erythematosus (SLE) Drugs Competitor Landscape by Players
3.1 Systemic Lupus Erythematosus (SLE) Drugs Sales by Manufacturers
3.1.1 Systemic Lupus Erythematosus (SLE) Drugs Sales by Manufacturers (2015-2020)
3.1.2 Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Systemic Lupus Erythematosus (SLE) Drugs Revenue by Manufacturers
3.2.1 Systemic Lupus Erythematosus (SLE) Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Systemic Lupus Erythematosus (SLE) Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Systemic Lupus Erythematosus (SLE) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Systemic Lupus Erythematosus (SLE) Drugs Revenue in 2019
3.2.5 Global Systemic Lupus Erythematosus (SLE) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Systemic Lupus Erythematosus (SLE) Drugs Price by Manufacturers
3.4 Systemic Lupus Erythematosus (SLE) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Systemic Lupus Erythematosus (SLE) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Systemic Lupus Erythematosus (SLE) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Systemic Lupus Erythematosus (SLE) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Systemic Lupus Erythematosus (SLE) Drugs Market Size by Type (2015-2020)
4.1.1 Global Systemic Lupus Erythematosus (SLE) Drugs Sales by Type (2015-2020)
4.1.2 Global Systemic Lupus Erythematosus (SLE) Drugs Revenue by Type (2015-2020)
4.1.3 Systemic Lupus Erythematosus (SLE) Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Systemic Lupus Erythematosus (SLE) Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Systemic Lupus Erythematosus (SLE) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Systemic Lupus Erythematosus (SLE) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Systemic Lupus Erythematosus (SLE) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Systemic Lupus Erythematosus (SLE) Drugs Market Size by Application (2015-2020)
5.1.1 Global Systemic Lupus Erythematosus (SLE) Drugs Sales by Application (2015-2020)
5.1.2 Global Systemic Lupus Erythematosus (SLE) Drugs Revenue by Application (2015-2020)
5.1.3 Systemic Lupus Erythematosus (SLE) Drugs Price by Application (2015-2020)
5.2 Systemic Lupus Erythematosus (SLE) Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Systemic Lupus Erythematosus (SLE) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Systemic Lupus Erythematosus (SLE) Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Systemic Lupus Erythematosus (SLE) Drugs by Country
6.1.1 North America Systemic Lupus Erythematosus (SLE) Drugs Sales by Country
6.1.2 North America Systemic Lupus Erythematosus (SLE) Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Systemic Lupus Erythematosus (SLE) Drugs Market Facts & Figures by Type
6.3 North America Systemic Lupus Erythematosus (SLE) Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Systemic Lupus Erythematosus (SLE) Drugs by Country
7.1.1 Europe Systemic Lupus Erythematosus (SLE) Drugs Sales by Country
7.1.2 Europe Systemic Lupus Erythematosus (SLE) Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Systemic Lupus Erythematosus (SLE) Drugs Market Facts & Figures by Type
7.3 Europe Systemic Lupus Erythematosus (SLE) Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs by Region
8.1.1 Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Sales by Region
8.1.2 Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Market Facts & Figures by Type
8.3 Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Systemic Lupus Erythematosus (SLE) Drugs by Country
9.1.1 Latin America Systemic Lupus Erythematosus (SLE) Drugs Sales by Country
9.1.2 Latin America Systemic Lupus Erythematosus (SLE) Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Systemic Lupus Erythematosus (SLE) Drugs Market Facts & Figures by Type
9.3 Central & South America Systemic Lupus Erythematosus (SLE) Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs by Country
10.1.1 Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Sales by Country
10.1.2 Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Anthera Pharmaceuticals
11.1.1 Anthera Pharmaceuticals Corporation Information
11.1.2 Anthera Pharmaceuticals Description and Business Overview
11.1.3 Anthera Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Anthera Pharmaceuticals Systemic Lupus Erythematosus (SLE) Drugs Products Offered
11.1.5 Anthera Pharmaceuticals Related Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Description and Business Overview
11.2.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GSK Systemic Lupus Erythematosus (SLE) Drugs Products Offered
11.2.5 GSK Related Developments
11.3 ImmuPharma
11.3.1 ImmuPharma Corporation Information
11.3.2 ImmuPharma Description and Business Overview
11.3.3 ImmuPharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 ImmuPharma Systemic Lupus Erythematosus (SLE) Drugs Products Offered
11.3.5 ImmuPharma Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Systemic Lupus Erythematosus (SLE) Drugs Products Offered
11.4.5 Johnson & Johnson Related Developments
11.1 Anthera Pharmaceuticals
11.1.1 Anthera Pharmaceuticals Corporation Information
11.1.2 Anthera Pharmaceuticals Description and Business Overview
11.1.3 Anthera Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Anthera Pharmaceuticals Systemic Lupus Erythematosus (SLE) Drugs Products Offered
11.1.5 Anthera Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Systemic Lupus Erythematosus (SLE) Drugs Market Estimates and Projections by Region
12.1.1 Global Systemic Lupus Erythematosus (SLE) Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Systemic Lupus Erythematosus (SLE) Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Systemic Lupus Erythematosus (SLE) Drugs Sales Forecast (2021-2026)
12.2.2 North America: Systemic Lupus Erythematosus (SLE) Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Systemic Lupus Erythematosus (SLE) Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Systemic Lupus Erythematosus (SLE) Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Systemic Lupus Erythematosus (SLE) Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Systemic Lupus Erythematosus (SLE) Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Systemic Lupus Erythematosus (SLE) Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Systemic Lupus Erythematosus (SLE) Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Systemic Lupus Erythematosus (SLE) Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Systemic Lupus Erythematosus (SLE) Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Systemic Lupus Erythematosus (SLE) Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Systemic Lupus Erythematosus (SLE) Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Systemic Lupus Erythematosus (SLE) Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Systemic Lupus Erythematosus (SLE) Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Systemic Lupus Erythematosus (SLE) Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Systemic Lupus Erythematosus (SLE) Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Systemic Lupus Erythematosus (SLE) Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Systemic Lupus Erythematosus (SLE) Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Systemic Lupus Erythematosus (SLE) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Systemic Lupus Erythematosus (SLE) Drugs Market Segments
Table 2. Ranking of Global Top Systemic Lupus Erythematosus (SLE) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Systemic Lupus Erythematosus (SLE) Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Corticosteroids
Table 5. Major Manufacturers of Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Table 6. Major Manufacturers of Anti-Inflammatories
Table 7. Major Manufacturers of Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
Table 8. Major Manufacturers of Antimalarials
Table 9. Major Manufacturers of BLyS-Specific Inhibitors or Monoclonal Antibodies (MAbS)
Table 10. Major Manufacturers of Immunosuppressive Agents/Immune Modulators
Table 11. Major Manufacturers of Anticoagulants
Table 12. Global Systemic Lupus Erythematosus (SLE) Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Systemic Lupus Erythematosus (SLE) Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 14. Global Systemic Lupus Erythematosus (SLE) Drugs Sales by Regions 2015-2020 (K MT)
Table 15. Global Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Regions (2015-2020)
Table 16. Global Systemic Lupus Erythematosus (SLE) Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Systemic Lupus Erythematosus (SLE) Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 18. Global Systemic Lupus Erythematosus (SLE) Drugs Sales Share by Manufacturers (2015-2020)
Table 19. Global Systemic Lupus Erythematosus (SLE) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Systemic Lupus Erythematosus (SLE) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Lupus Erythematosus (SLE) Drugs as of 2019)
Table 21. Systemic Lupus Erythematosus (SLE) Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Systemic Lupus Erythematosus (SLE) Drugs Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Systemic Lupus Erythematosus (SLE) Drugs Price (2015-2020) (USD/MT)
Table 24. Systemic Lupus Erythematosus (SLE) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Systemic Lupus Erythematosus (SLE) Drugs Product Type
Table 26. Date of International Manufacturers Enter into Systemic Lupus Erythematosus (SLE) Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Systemic Lupus Erythematosus (SLE) Drugs Sales by Type (2015-2020) (K MT)
Table 29. Global Systemic Lupus Erythematosus (SLE) Drugs Sales Share by Type (2015-2020)
Table 30. Global Systemic Lupus Erythematosus (SLE) Drugs Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Share by Type (2015-2020)
Table 32. Systemic Lupus Erythematosus (SLE) Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 33. Global Systemic Lupus Erythematosus (SLE) Drugs Sales by Application (2015-2020) (K MT)
Table 34. Global Systemic Lupus Erythematosus (SLE) Drugs Sales Share by Application (2015-2020)
Table 35. North America Systemic Lupus Erythematosus (SLE) Drugs Sales by Country (2015-2020) (K MT)
Table 36. North America Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Country (2015-2020)
Table 37. North America Systemic Lupus Erythematosus (SLE) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Country (2015-2020)
Table 39. North America Systemic Lupus Erythematosus (SLE) Drugs Sales by Type (2015-2020) (K MT)
Table 40. North America Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Type (2015-2020)
Table 41. North America Systemic Lupus Erythematosus (SLE) Drugs Sales by Application (2015-2020) (K MT)
Table 42. North America Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Application (2015-2020)
Table 43. Europe Systemic Lupus Erythematosus (SLE) Drugs Sales by Country (2015-2020) (K MT)
Table 44. Europe Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Country (2015-2020)
Table 45. Europe Systemic Lupus Erythematosus (SLE) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Country (2015-2020)
Table 47. Europe Systemic Lupus Erythematosus (SLE) Drugs Sales by Type (2015-2020) (K MT)
Table 48. Europe Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Systemic Lupus Erythematosus (SLE) Drugs Sales by Application (2015-2020) (K MT)
Table 50. Europe Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Sales by Region (2015-2020) (K MT)
Table 52. Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Sales by Type (2015-2020) (K MT)
Table 56. Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Sales by Application (2015-2020) (K MT)
Table 58. Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Application (2015-2020)
Table 59. Latin America Systemic Lupus Erythematosus (SLE) Drugs Sales by Country (2015-2020) (K MT)
Table 60. Latin America Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Systemic Lupus Erythematosus (SLE) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Country (2015-2020)
Table 63. Latin America Systemic Lupus Erythematosus (SLE) Drugs Sales by Type (2015-2020) (K MT)
Table 64. Latin America Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Type (2015-2020)
Table 65. Latin America Systemic Lupus Erythematosus (SLE) Drugs Sales by Application (2015-2020) (K MT)
Table 66. Latin America Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Sales by Country (2015-2020) (K MT)
Table 68. Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Sales by Type (2015-2020) (K MT)
Table 72. Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Sales by Application (2015-2020) (K MT)
Table 74. Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Application (2015-2020)
Table 75. Anthera Pharmaceuticals Corporation Information
Table 76. Anthera Pharmaceuticals Description and Major Businesses
Table 77. Anthera Pharmaceuticals Systemic Lupus Erythematosus (SLE) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Anthera Pharmaceuticals Product
Table 79. Anthera Pharmaceuticals Recent Development
Table 80. GSK Corporation Information
Table 81. GSK Description and Major Businesses
Table 82. GSK Systemic Lupus Erythematosus (SLE) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. GSK Product
Table 84. GSK Recent Development
Table 85. ImmuPharma Corporation Information
Table 86. ImmuPharma Description and Major Businesses
Table 87. ImmuPharma Systemic Lupus Erythematosus (SLE) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. ImmuPharma Product
Table 89. ImmuPharma Recent Development
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Major Businesses
Table 92. Johnson & Johnson Systemic Lupus Erythematosus (SLE) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Johnson & Johnson Product
Table 94. Johnson & Johnson Recent Development
Table 95. Global Systemic Lupus Erythematosus (SLE) Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 96. Global Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 97. Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 98. Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 99. North America: Systemic Lupus Erythematosus (SLE) Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 100. North America: Systemic Lupus Erythematosus (SLE) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Europe: Systemic Lupus Erythematosus (SLE) Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 102. Europe: Systemic Lupus Erythematosus (SLE) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Asia Pacific: Systemic Lupus Erythematosus (SLE) Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 104. Asia Pacific: Systemic Lupus Erythematosus (SLE) Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 105. Latin America: Systemic Lupus Erythematosus (SLE) Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 106. Latin America: Systemic Lupus Erythematosus (SLE) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Middle East and Africa: Systemic Lupus Erythematosus (SLE) Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 108. Middle East and Africa: Systemic Lupus Erythematosus (SLE) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 110. Key Challenges
Table 111. Market Risks
Table 112. Main Points Interviewed from Key Systemic Lupus Erythematosus (SLE) Drugs Players
Table 113. Systemic Lupus Erythematosus (SLE) Drugs Customers List
Table 114. Systemic Lupus Erythematosus (SLE) Drugs Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Systemic Lupus Erythematosus (SLE) Drugs Product Picture
Figure 2. Global Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Corticosteroids Product Picture
Figure 4. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Product Picture
Figure 5. Anti-Inflammatories Product Picture
Figure 6. Disease-Modifying Anti-Rheumatic Drugs (DMARDs) Product Picture
Figure 7. Antimalarials Product Picture
Figure 8. BLyS-Specific Inhibitors or Monoclonal Antibodies (MAbS) Product Picture
Figure 9. Immunosuppressive Agents/Immune Modulators Product Picture
Figure 10. Anticoagulants Product Picture
Figure 11. Global Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Application in 2020 & 2026
Figure 12. Intravenous
Figure 13. Sub-Cutaneous
Figure 14. Oral
Figure 15. Topical
Figure 16. Systemic Lupus Erythematosus (SLE) Drugs Report Years Considered
Figure 17. Global Systemic Lupus Erythematosus (SLE) Drugs Market Size 2015-2026 (US$ Million)
Figure 18. Global Systemic Lupus Erythematosus (SLE) Drugs Sales 2015-2026 (K MT)
Figure 19. Global Systemic Lupus Erythematosus (SLE) Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Region (2015-2020)
Figure 21. Global Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Region in 2019
Figure 22. Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Region (2015-2020)
Figure 23. Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Region in 2019
Figure 24. Global Systemic Lupus Erythematosus (SLE) Drugs Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Systemic Lupus Erythematosus (SLE) Drugs Revenue in 2019
Figure 26. Systemic Lupus Erythematosus (SLE) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Type (2015-2020)
Figure 28. Global Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Type in 2019
Figure 29. Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Type (2015-2020)
Figure 30. Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Type in 2019
Figure 31. Global Systemic Lupus Erythematosus (SLE) Drugs Market Share by Price Range (2015-2020)
Figure 32. Global Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Application (2015-2020)
Figure 33. Global Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Application in 2019
Figure 34. Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Application (2015-2020)
Figure 35. Global Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Application in 2019
Figure 36. North America Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 37. North America Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Country in 2019
Figure 39. North America Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Country in 2019
Figure 40. U.S. Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 41. U.S. Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 43. Canada Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America Systemic Lupus Erythematosus (SLE) Drugs Market Share by Type in 2019
Figure 45. North America Systemic Lupus Erythematosus (SLE) Drugs Market Share by Application in 2019
Figure 46. Europe Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 47. Europe Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Country in 2019
Figure 49. Europe Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Country in 2019
Figure 50. Germany Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Germany Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. France Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 55. U.K. Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 57. Italy Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 59. Russia Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe Systemic Lupus Erythematosus (SLE) Drugs Market Share by Type in 2019
Figure 61. Europe Systemic Lupus Erythematosus (SLE) Drugs Market Share by Application in 2019
Figure 62. Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 63. Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Region in 2019
Figure 65. Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Region in 2019
Figure 66. China Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. China Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. Japan Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. South Korea Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. India Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Australia Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Taiwan Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Indonesia Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Thailand Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 83. Malaysia Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 85. Philippines Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 87. Vietnam Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Market Share by Type in 2019
Figure 89. Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Market Share by Application in 2019
Figure 90. Latin America Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 91. Latin America Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Country in 2019
Figure 93. Latin America Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Country in 2019
Figure 94. Mexico Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 95. Mexico Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 97. Brazil Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 99. Argentina Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America Systemic Lupus Erythematosus (SLE) Drugs Market Share by Type in 2019
Figure 101. Latin America Systemic Lupus Erythematosus (SLE) Drugs Market Share by Application in 2019
Figure 102. Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 103. Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share by Country in 2019
Figure 106. Turkey Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 107. Turkey Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 109. Saudi Arabia Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 111. U.A.E Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Market Share by Type in 2019
Figure 113. Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Market Share by Application in 2019
Figure 114. North America Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. North America Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Europe Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Asia Pacific Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Latin America Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Middle East and Africa Systemic Lupus Erythematosus (SLE) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…- 自己免疫治療薬の世界市場（～2026年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…
- 抗炎症薬の世界市場（～2026年） Market Analysis and Insights: Global Anti-inflammatory Drugs Market The global Anti-inflammatory Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti-inflammatory Drugs Scope and Market Size Anti-inflammatory Dru…
- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…
- 抗腫瘍薬の世界市場（～2026年） Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It ha…